ResearcherFujian Medical UniversityActive in the last 2 years

Xianlin Han

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5124701043. Sources: OpenAlex.

Their work

Papers: 5 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 19

Papers, trials and grants by year

2026: 5 papers

Papers 5

Integrating Radiomics and Computational Pathology to Predict Early Recurrence of Pancreatic Ductal Adenocarcinoma and Uncover Its Biological Basis in Tumor Mic… Co-author DOI 10.1002/advs.202523985 ↗
Tumor-educated adipocytes promote muscle wasting via EV-packaged miR-221-3p targeting IRS1 in pancreatic cancer cachexia. Co-author DOI 10.1016/j.canlet.2026.218795 ↗
A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ccell.2026.03.021 ↗
Proposing an Optimized Prediction Model for Pancreatic Cancer Based on Mendelian Randomization Analysis of Fibrinogen Levels and Urinary Protein Excretion Rate. Last author DOI 10.1177/11795549251392490 ↗
Clinical quality of large language model answers to questions about pancreatic cancer Co-author DOI 10.21203/rs.3.rs-10624412/v1 ↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wenming Wu · 2 shared papers, 2026 · strength 0.55
- Paper Clinical quality of large language model answers to questions about pancreatic cancer DOI 10.21203/rs.3.rs-10624412/v1 ↗
- Paper Tumor-educated adipocytes promote muscle wasting via EV-packaged miR-221-3p targeting IRS1 in pancreatic cancer cachexi… DOI 10.1016/j.canlet.2026.218795 ↗
Huanwen Wu · 2 shared papers, 2026 · strength 0.50
- Paper Tumor-educated adipocytes promote muscle wasting via EV-packaged miR-221-3p targeting IRS1 in pancreatic cancer cachexi… DOI 10.1016/j.canlet.2026.218795 ↗
- Paper Integrating Radiomics and Computational Pathology to Predict Early Recurrence of Pancreatic Ductal Adenocarcinoma and U… DOI 10.1002/advs.202523985 ↗
Qi Wu · 1 shared paper, 2026 · strength 0.33
- Paper Proposing an Optimized Prediction Model for Pancreatic Cancer Based on Mendelian Randomization Analysis of Fibrinogen L… DOI 10.1177/11795549251392490 ↗
Xiao Han · 1 shared paper, 2026 · strength 0.33
- Paper Proposing an Optimized Prediction Model for Pancreatic Cancer Based on Mendelian Randomization Analysis of Fibrinogen L… DOI 10.1177/11795549251392490 ↗
Ruohan Cui · 1 shared paper, 2026 · strength 0.29
- Paper Clinical quality of large language model answers to questions about pancreatic cancer DOI 10.21203/rs.3.rs-10624412/v1 ↗
Wanli Liu · 1 shared paper, 2026 · strength 0.26
- Paper Tumor-educated adipocytes promote muscle wasting via EV-packaged miR-221-3p targeting IRS1 in pancreatic cancer cachexi… DOI 10.1016/j.canlet.2026.218795 ↗
Aoyi Xiao · 1 shared paper, 2026 · strength 0.26
- Paper Tumor-educated adipocytes promote muscle wasting via EV-packaged miR-221-3p targeting IRS1 in pancreatic cancer cachexi… DOI 10.1016/j.canlet.2026.218795 ↗
Huadan Xue · 1 shared paper, 2026 · strength 0.24
- Paper Integrating Radiomics and Computational Pathology to Predict Early Recurrence of Pancreatic Ductal Adenocarcinoma and U… DOI 10.1002/advs.202523985 ↗
Cheng Si-Hang · 1 shared paper, 2026 · strength 0.24
- Paper Integrating Radiomics and Computational Pathology to Predict Early Recurrence of Pancreatic Ductal Adenocarcinoma and U… DOI 10.1002/advs.202523985 ↗
Jing Wu · 1 shared paper, 2026 · strength 0.24
- Paper Integrating Radiomics and Computational Pathology to Predict Early Recurrence of Pancreatic Ductal Adenocarcinoma and U… DOI 10.1002/advs.202523985 ↗
Meilian Zhuo · 1 shared paper, 2026 · strength 0.21
- Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021 ↗
Ruizhe He · 1 shared paper, 2026 · strength 0.21
- Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021 ↗
Mingyang Liu · 1 shared paper, 2026 · strength 0.21
- Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021 ↗
Mo Chen · 1 shared paper, 2026 · strength 0.21
- Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021 ↗
Junya Peng · 1 shared paper, 2026 · strength 0.21
- Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021 ↗
Menghua Dai · 1 shared paper, 2026 · strength 0.21
- Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021 ↗
Charles J. David · 1 shared paper, 2026 · strength 0.21
- Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021 ↗
Weibin Wang · 1 shared paper, 2026 · strength 0.21
- Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021 ↗
Yupei Zhao · 1 shared paper, 2026 · strength 0.21
- Paper A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccell.2026.03.021 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.